Clinical trial

Trial of Ginsenoside Compound K (GCK) Tablet in Patients With Rheumatoid Arthritis

NCT03755258

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2017-03-16

PhasePHASE1

Study timeline

Study start (actual)2017-03-16Date precision: day

Registry last updated2018-11-27

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Early Rheumatoid Arthritisunresolved

Interventions

GCK 100 mg + Placebo 200 mgDRUG

GCK 200 mg + Placebo 100 mgDRUG

Placebo 300mgDRUG

Sponsors & collaborators

Zhejiang Hisun Pharmaceutical Co. Ltd.lead sponsor

Mapped research locations

BeijingBeijing Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03755258 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.